ICD-10 Code E11.40: Type 2 Diabetes with Diabetic Neuropathy, Unspecified

Key Takeaways

E11.40 is a billable ICD-10-CM code for Type 2 diabetes mellitus with diabetic neuropathy, unspecified, valid for fiscal year 2026

Use E11.40 only when the clinical record does not specify the neuropathy type: mononeuropathy, polyneuropathy, autonomic, or amyotrophy

Switch to a more specific code (E11.41-E11.44) as soon as the provider documents the neuropathy subtype to reduce audit risk and denial exposure

Pabau’s structured client records and digital forms help clinicians capture neuropathy specificity at the point of care, supporting cleaner ICD-10 code E11.40 coding workflows

Diabetic neuropathy affects an estimated 50% of people with diabetes over their lifetime, making it one of the most commonly coded complications in endocrinology, primary care, and internal medicine. Yet it is also one of the most frequently undercoded. When a provider documents neuropathy without specifying its type, coders reach for ICD-10 code E11.40 by default. The problem is that “default” and “correct” are not always the same thing.

E11.40 is valid, billable, and appropriate in specific circumstances. But relying on it when a more precise code is available creates audit exposure and can delay reimbursement. This reference covers the full clinical and billing picture: when E11.40 applies, how it compares to related codes in the E11.4x series, documentation requirements, and crosswalk guidance for legacy ICD-9-CM users.

ICD-10 Code E11.40: Definition and Clinical Description

ICD-10 code E11.40 classifies Type 2 diabetes mellitus with diabetic neuropathy, unspecified. It sits within ICD-10-CM Chapter 4 (Endocrine, nutritional and metabolic diseases, E00-E89), under the diabetes mellitus subrange E08-E13. According to the Centers for Medicare and Medicaid Services (CMS), E11.40 is a valid, billable, specific code for fiscal year 2026 with no changes to its description or inclusion notes from prior years.

The “unspecified” qualifier is the critical element. It tells the payer that the provider confirmed diabetic neuropathy is present and linked to the patient’s Type 2 diabetes, but the clinical documentation does not further identify the neuropathy subtype. This is a legitimate clinical scenario. A provider may note “diabetic neuropathy” on the encounter without specifying whether it is peripheral, autonomic, or focal.

Clinically, patients coded under E11.40 typically present with symptoms that suggest nerve involvement: pain, tingling, numbness, or weakness. Without further workup or specialist evaluation to classify the neuropathy, E11.40 is the correct assignment. It is not a placeholder or a coding shortcut. It is an accurate code for an accurately documented clinical status. For practices managing metabolic health documentation across large diabetic patient panels, understanding this distinction prevents both undercoding and overcoding errors.

Synonyms and Inclusion Notes

The ICD-10-CM tabular list includes several synonymous presentations under E11.40:

• Asymptomatic diabetic neuropathy in Type 2 diabetes
• Diabetic neuropathy NOS (not otherwise specified) with Type 2 diabetes
• Neuropathy due to Type 2 diabetes mellitus, unspecified type
• Tingling or numbness without further neuropathy classification in a Type 2 diabetic patient

These synonyms confirm that E11.40 applies even when symptoms are present but the clinical record stops short of a subtype classification. Providers in functional medicine practices working with complex diabetic patients often encounter exactly this scenario during initial assessments before specialist referral.

Billable Status and Code Validity for 2026

E11.40 is a fully billable ICD-10-CM diagnosis code. It carries a “Billable/Specific Code” designation, meaning it is valid for submission on HIPAA-covered transactions without requiring a more specific child code. The World Health Organization’s ICD-10 classification underpins the structure, while the National Center for Health Statistics (NCHS) maintains the ICD-10-CM clinical modification used in the United States.

For fiscal year 2026, E11.40 remains unchanged. No new inclusion notes, exclusion flags, or sequencing guidance has been added that would affect its routine use. Practices should verify current CMS update files at the start of each fiscal year to confirm code stability, as the ICD-10-CM annual update cycle can add or retire codes in any category.

When to Use E11.40: Clinical Scenarios

The sequencing and selection rule for E11.40 rests on one principle: use it when the neuropathy is confirmed but the subtype is absent from the documentation. Three clinical scenarios make this code appropriate:

1. Neuropathy confirmed without subtype documentation: The provider’s note states “diabetic neuropathy” and the patient has a documented Type 2 diabetes diagnosis, but no further classification (mononeuropathy, polyneuropathy, autonomic) appears anywhere in the encounter record.
2. Symptoms present, workup pending: The patient presents with pain, tingling, or numbness attributable to diabetes. A referral to neurology or additional nerve conduction studies are ordered, but results are not yet available at the time of coding.
3. Existing asymptomatic neuropathy, routine monitoring: The patient’s diabetes management record notes a prior diagnosis of diabetic neuropathy without specificity, and the current encounter is a follow-up with no new characterization of the neuropathy type.

Using structured digital intake forms that prompt providers to classify neuropathy type during assessment can significantly reduce E11.40 usage in favor of more specific codes. This benefits both the payer (clearer clinical picture) and the practice (reduced audit scrutiny of unspecified codes).

E11.40 vs. E11.41, E11.42, E11.43, and E11.44: Code Comparison

The E11.4x series covers all neurological complications of Type 2 diabetes. E11.40 is the parent-level unspecified code. Each sibling code requires additional documentation to justify its use. The table below shows how to distinguish them.

The most common coding question involves E11.40 vs. E11.42. Polyneuropathy (E11.42) is the most prevalent form of diabetic neuropathy, accounting for the majority of neuropathy presentations in Type 2 diabetic patients. If the provider documents “peripheral neuropathy,” “distal symmetric polyneuropathy,” or “stocking-glove distribution,” E11.42 is the appropriate code. Review ICD-10 documentation guidance for related specificity principles across other diagnostic categories.

E11.40 vs. E10.40: Type 1 vs. Type 2

E10.40 is the equivalent code for Type 1 diabetes mellitus with diabetic neuropathy, unspecified. The two codes are never interchangeable. The diabetes type (Type 1 or Type 2) must be confirmed in the clinical record before assigning either code. Type 1 and Type 2 diabetes have distinct pathophysiology and different coding hierarchies within ICD-10-CM. Assigning E11.40 to a Type 1 diabetic patient, or E10.40 to a Type 2 patient, is a coding error that payers may flag during claims review.

Documentation Requirements for Diabetic Neuropathy, Unspecified

Accurate ICD-10 code E11.40 assignment depends on what the provider documents. Coders must not infer neuropathy from symptom descriptions alone. The encounter note must contain a clinical statement that establishes the causal link between the patient’s Type 2 diabetes and the neurological manifestation.

According to CMS ICD-10-CM Official Guidelines, the provider must document the relationship between diabetes and any associated condition. The guidelines state that for Type 2 diabetic complications, “it is appropriate to attribute a condition to the diabetes if the provider documents the linkage.” For neuropathy specifically, a note reading “neuropathy due to diabetes” or “diabetic neuropathy” satisfies this requirement.

Minimum Documentation Checklist

• Confirmed Type 2 diabetes diagnosis: Active problem list entry or explicit mention in the encounter note
• Neuropathy established by provider: Direct statement linking neuropathy to diabetes (not just patient-reported symptoms)
• No subtype specified: No mention of mononeuropathy, polyneuropathy, autonomic neuropathy, or amyotrophy anywhere in the encounter documentation
• Causal attribution documented: “Due to diabetes,” “diabetic neuropathy,” or equivalent clinical language present

Maintaining structured patient records that capture complication types at each encounter reduces the documentation gaps that force coders to default to E11.40. When records are structured with condition-specific fields, providers are naturally prompted to specify neuropathy subtype rather than leaving it open. This is where HIPAA-compliant documentation practices intersect with coding accuracy.

Reduce E11.40 Undercoding with Structured Clinical Records

Pabau's digital forms and structured patient records prompt clinicians to document neuropathy subtypes at point of care, reducing unspecified code usage and supporting cleaner claims submissions.

Book a demo

Coding Guidelines and Sequencing Rules

CMS ICD-10-CM coding guidelines treat diabetes mellitus codes as etiology/manifestation pairs in some scenarios, but for E11.40, no additional manifestation code is required. The code is self-contained. However, coders must consider several important sequencing and combination rules.

Principal Diagnosis Sequencing

When a patient with Type 2 diabetes is admitted or seen primarily for the neuropathy, E11.40 may serve as the principal diagnosis. When the encounter is primarily for diabetes management and neuropathy is a secondary finding, the sequencing order should reflect the reason for the visit. The claims management workflow within practice management software can enforce correct sequencing by allowing coders to flag primary vs. secondary diagnoses before submission.

Comorbidity Coding

E11.40 is frequently coded alongside other diabetes complications and comorbidities. Common combination coding scenarios include:

• E11.40 + I10: Type 2 diabetes with unspecified neuropathy and essential hypertension (both coded separately; no excludes note prohibits this combination)
• E11.40 + N18.x: Type 2 diabetes with neuropathy and chronic kidney disease (CKD stage specified by the N18 code)
• E11.40 + E11.65: Type 2 diabetes with hyperglycemia, when both are documented and addressed in the same encounter
• E11.40 + Z79.4: Long-term (current) use of insulin, when applicable
• E11.40 + Z79.84: Long-term (current) use of oral hypoglycemic drugs, when applicable
• E11.40 + Z79.85: Long-term (current) use of injectable non-insulin antidiabetic drugs (e.g. GLP-1 receptor agonists), when applicable

The E11 code family carries an official ICD-10-CM instruction: “Use additional code to identify control using” Z79.4, Z79.84, or Z79.85 when applicable. This is a mandatory companion coding requirement – omitting the applicable Z79 code when the patient’s medication regimen is documented leaves the claim incomplete for risk adjustment and quality reporting purposes.

Thorough compliance management processes include auditing combination coding patterns to ensure that comorbidity codes are added when documented and not omitted to simplify claims. Refer to related ICD-10 coding reference guides for analogous combination coding logic in other diagnostic categories.

ICD-9-CM Crosswalk and Legacy Reference

For practices maintaining historical records or working with legacy billing data, the ICD-9-CM predecessor to E11.40 is 250.60 (Diabetes with neurological manifestations, Type 2 or unspecified, not stated as uncontrolled). This crosswalk is relevant for claims audits, retrospective chart reviews, and quality reporting that spans the ICD-9 to ICD-10 transition period (pre- and post-October 2015).

The ICD-9 code 250.60 was broader than E11.40. It did not distinguish between neuropathy subtypes in the same granular way the ICD-10-CM E11.4x series does. Providers reviewing historical neuropathy coding should use the PGM Billing ICD-10 lookup tool to verify bidirectional crosswalk accuracy when converting legacy records.

For audit trail purposes, documenting the crosswalk rationale in the medical record is best practice, particularly when a historical 250.60 code is being mapped to a specific E11.4x subtype (rather than defaulting to E11.40) based on newly available clinical information. Review additional neurological ICD-10 coding guidance for related crosswalk principles.

Audit Risk and Payer Considerations

Unspecified codes like E11.40 attract payer scrutiny when used at high frequency across a practice’s diabetic patient population. While E11.40 is clinically appropriate in the scenarios described above, payers including Medicare Administrative Contractors (MACs) conduct data analysis on unspecified code utilization rates. A practice where 80% of diabetic neuropathy claims use E11.40 rather than E11.42 or E11.43 may trigger a documentation review.

Three practical steps reduce this risk without requiring additional clinical work:

1. Provider education: Clinicians should understand that documenting “peripheral neuropathy” or “distal symmetric neuropathy” in patients with Type 2 diabetes enables E11.42 assignment rather than E11.40. This single word change in the note can materially improve coding specificity.
2. Query workflow: When a coder encounters an encounter note with only “diabetic neuropathy,” a clarifying query to the provider before final billing can capture the specificity needed for a more precise code.
3. Specificity tracking: Monitor the E11.40-to-E11.4x ratio quarterly. A rising ratio of unspecified to specified codes may indicate a documentation gap in provider charting.

Practices using AI-assisted clinical documentation tools that structure encounter notes around condition-specific fields can reduce unspecified code usage by prompting providers to classify neuropathy type during charting rather than leaving it open for the coder to manage.

Expert Picks

Need to streamline diabetic patient documentation workflows? Pabau Digital Forms lets clinicians build structured intake templates that prompt neuropathy subtype classification at point of care.

Managing complex ICD-10 coding across a multi-provider practice? Pabau Claims Management supports diagnosis code sequencing and comorbidity tracking before claim submission.

Looking for additional ICD-10 diagnostic code references? ICD-10 code reference guides on Pabau cover a range of diagnostic categories with the same coding specificity framework.

Want AI-powered support for clinical note accuracy? Pabau Echo AI assists practitioners in capturing structured clinical information that supports precise ICD-10 code E11.40 assignments.

Conclusion

ICD-10 code E11.40 is a legitimate, billable code for Type 2 diabetes with diabetic neuropathy when the neuropathy type is not specified in the clinical record. Its appropriate use requires confirmed causal documentation from the provider and the absence of any subtype specification that would support E11.41, E11.42, E11.43, or E11.44. Overuse of E11.40 when more specific codes are available increases audit risk without improving clinical accuracy.

Practices that build specificity prompts into their clinical workflows and that use structured documentation tools tend to see lower E11.40 utilization rates and fewer payer queries on diabetic neuropathy claims. To see how Pabau’s structured records and digital forms support accurate diabetic neuropathy coding at the point of care, book a demo with our practice management team.

Frequently Asked Questions